CHRONIC KIDNEY DISEASE MANAGEMENT IN PRIMARY CARE HANDBOOK REFRESHED FOR HCPs
Breonny Robson, GM Clinical and Research
Kidney Health Australia
Dr Chris Bollen GP, Oakden Medical Centre &
PEAK Committee Member, Kidney Health Australia
Professor Shilpa Jesudason, Nephrologist
Professor of Medicine, University of Adelaide,
Director of Dialysis, Royal Adelaide Hospital &
PEAK Committee Member, Kidney Health Australia
Chris Picton MP, Minister for Health and Wellbeing
Government of South Australia
Kidney Health Australia’s latest kidney disease guide for primary care practitioners is expected to be pivotal in slowing down the rates of kidney failure, which have doubled in the past 20 years and if left unchecked will grow by a further 42% by 2030, according to the health charity.
With specific reference to new kidney treatments and culturally safe kidney care for First Nations Australians, the 5th edition of Chronic Kidney Disease (CKD) Management in Primary Care handbook, known as the ‘kidney bible’, is a significant step-up in enabling earlier diagnosis of kidney disease for GPs and other front-line healthcare professionals.
The number of Australians treated for kidney failure has doubled in the last two decades, causing widespread treatment shortages, increasing costs, and plunging thousands of Australians into highly invasive and life-altering dialysis. With 1.8 million people currently unaware they have kidney disease, this number will only continue to grow.
Breonny Robson, General Manager, Clinical and Research at Kidney Health Australia, said: “The new edition of the GP handbook helps health professionals working in primary care to identify people at risk of CKD in their practice and proactively diagnose CKD. It outlines key strategies to slow the progression of CKD and reduce cardiovascular risk, including simple colour-coded action plans for different stages of the disease.”
Ms Robson added, “It’s an exciting time in CKD care, with new treatments now available that have been shown to slow the progression of CKD to kidney failure by 15 years or more. The handbook contains significant new information on using these medications in people with CKD so that their health outcomes and quality of life can be extended for many years to come.”
The handbook is endorsed by Australian and New Zealand Society of Nephrology (ANZSN), the Renal Society of Australasia (RSA) and the Australian Primary Healthcare Nurses Association (APNA) and Australian College of Rural and Remote Medicine (ACRRM). It has been approved as an Acceptable Clinical Resource by the Royal Australian College of General Practitioners (RACGP).
South Australian Minister of Health and Wellbeing Chris Picton launched the handbook at an event on World Kidney Day, 14th March, at Royal Adelaide Hospital.
The handbook is available from Kidney Health Australia in hardcopy or free download here https://kidney.org.au/health-professionals/ckd-management-handbook
-
Empowered nurses leading digital health enablement
Nurses have a pivotal role to play in the widespread implementation and adoption of digital health technologies throughout the healthcare sector for the primary purpose of improving safety and quality of patient care.
Australian Health Journal talked to two of Australian top leaders in nursing and in digital health on how the role of nursing is pivotal to the success of digital health in the Australian health system.
-
Strengthening Evidence Through Health Research Where Most People Access Healthcare
In February 2025, the Australian Government committed over $22 million for primary care research, including $5.2m awarded to Professor Michael Kidd, Director of the International Centre for Future Health Systems at UNSW and recently appointed Australia’s Chief Medical Officer, to lead the establishment of one of the largest research collaborations in Australia focused on improving primary care.
The Royal Australian College of GPs says a new national multidisciplinary consortium for primary care research is a positive step forward to improve patient care.
-
Mission to raise awareness of sarcoma and need for clinical trial funding
Sarcoma, a rare and aggressive cancer, remains the deadliest cancer for children and young adults, accounting for nearly one third (30%) of cancer-related deaths among those aged 15–24 and one tenth (10%) of those aged 0–14. Further, still severely under-diagnosed, sarcoma only accounts for one sixth (15%) of all cancer diagnoses in the 15 – 24 age group, and less than a tenth (8%) among children under 10.
